Cancer control in India - Role of cancer registries
Cancer control in India - Role of cancer registries
Choosing Wisely: ctDNA/ Precision Oncology in colorectal cancers
Tarlatamab for SCLC: Subgroup analysis shows benefit regardless of previous chemo or anti-PD-(L)1 use
ESMO 2025: Highlights and analysis
Best practice in precision medicine for prostate cancer
ESMO 2025: Latest in EGFR mutant NSCLC
Improving efficacy and toxicity reporting - and treatment insights from an oncologist patient
Advancements in gastrointestinal cancer treatments at ASCO 2025
Unlocking biomarkers: Transforming immunotherapy outcomes
Updates on gastrointestinal cancer treatments ASCO 2025
Clinical advances in cancer molecular testing: the patient's perspective
Florida Atlantic University and Memorial Cancer Institute collaboration